Related Experiment Video
Updated: May 8, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Organic anion-transporting polypeptides: a novel approach for cancer therapy
1State Engineering Laboratory of Bio-Resources Eco-Utilization, Northeast Forestry University, Ministry of Education , Harbin , China and.
Abstract:
Organic anion-transporting polypeptides (OATPs) encoded by the SLCO genes constitute an important transporter superfamily that mediates transmembrane transport of various clinical drugs and endogenous nutrients. Eleven human OATPs with different transport functions are expressed in various tissues. Bile acids, steroid hormone conjugates, prostaglandins, testosterone and thyroid hormones that promote cell proliferation are typical substrates of OATPs. Many important clinical drugs have been identified as substrates of OATP1B1, OATP1B3, OATP2B1 and OATP1A2. Liver-specific OATP1B1 and OATP1B3 as well as testis-specific OATP6A1 are expressed in malignancies and can act as biomarkers for many tumours. Various studies have shown the associations of genetic polymorphisms in OATP genes with the uptake pharmacokinetics of their substrates. Because of their abundant expression in tumours and their high transport activity for many cancer drugs, OATPs should be considered as important therapeutic targets in anti-cancer drug design.
Insights
Organic anion-transporting polypeptides (OATPs) are crucial transporters for drugs and nutrients. Their expression in tumors highlights their potential as anti-cancer drug targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Organic anion-transporting polypeptides (OATPs), encoded by SLCO genes, form a vital transporter superfamily.
- They facilitate transmembrane transport of diverse drugs and endogenous compounds, including bile acids, hormones, and prostaglandins.
- Eleven human OATPs exhibit distinct transport functions and tissue-specific expression patterns.
Purpose of the Study:
- To review the role of OATPs in drug transport and their significance in cancer.
- To highlight OATPs as potential biomarkers and therapeutic targets in oncology.
Main Methods:
- Literature review of studies on OATP function, substrate specificity, and genetic polymorphisms.
- Analysis of OATP expression in normal tissues and malignancies.
- Evaluation of OATP involvement in the pharmacokinetics of clinical drugs.
Main Results:
- OATPs transport numerous clinically relevant drugs, with OATP1B1, OATP1B3, OATP2B1, and OATP1A2 being key transporters.
- Liver-specific OATP1B1 and OATP1B3, along with testis-specific OATP6A1, are upregulated in various cancers, serving as potential biomarkers.
- Genetic variations in OATP genes influence substrate uptake and pharmacokinetics.
Conclusions:
- OATPs are integral to drug and nutrient transport, with specific isoforms implicated in cancer progression.
- Their expression in tumors and role in transporting anti-cancer drugs position OATPs as significant therapeutic targets for novel anti-cancer drug development.
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
ABC Transporters: Exporter
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
